Commenced in January 2007
Frequency: Monthly
Edition: International
Paper Count: 30073
Cereals' Products with Red Grape and Walnut Extracts as Functional Foods for Prevention of Kidney Dysfunction

Authors: Sahar Y. Al-Okbi, Doha A. Mohamed, Thanaa E. Hamed, Ahmed Ms Hussein

Abstract:

In the present research, two nutraceuticals made from red grape and walnut that showed previously to improve kidney dysfunction were incorporated separately into functional foods' bread made from barley and rice bran. The functional foods were evaluated in rats in which chronic renal failure was induced through feeding diet rich in adenine and phosphate (APD). The evaluation based on assessing kidney function, oxidative stress, inflammatory biomarkers and body weight gain. Results showed induction of chronic kidney failure reflected in significant increase in plasma urea, creatinine, malondialdehyde, tumor necrosis factor- α and low density lipoprotein cholesterol along with significant reduction of plasma albumin, and total antioxidant and creatinine clearance and body weight gain on feeding APD compared to control healthy group. Feeding the functional foods produced amelioration in the different biochemical parameters and body weight gain indicating improvement in kidney function.

Keywords: Functional food, kidney dysfunction, rats.

Digital Object Identifier (DOI): doi.org/10.5281/zenodo.1087021

Procedia APA BibTeX Chicago EndNote Harvard JSON MLA RIS XML ISO 690 PDF Downloads 1924

References:


[1] N. A. G. Santos, C. S. Catão, N. M. Martins, C. Curti, M. L. P. Bianchi, and A. C. Santos, “Cisplatin-induced nephrotoxicity is associated with oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria,” Archives of Toxicology, 81 (7), 495-504, 2007.
[2] N. D. Vaziri, and K. C. Norris, “Reasons for the lack of salutary effects of cholesterol-lowering interventions in end-stage renal disease populations” Blood Purif., 35(1-3), 31-6, 2013.
[3] M.C. Martin-Mateo, M. Sanchez-Portugal, S. Iglesias, A. de Paula, and J. Bustamante, “Oxidative stress in chronic renal failure,” Ren. Fail., 21, 155– 167, 1999.
[4] J. Galle, K. Heermeier, and C. Wanner, “Atherogenic lipoproteins, oxidative stress and cell death,” Kidney Int., 56 (Suppl. 71), S62–S65, 1999.
[5] R. A. Moreau, P. Bregitzer, K. Liu, and K. B. Hicks, “Compositional equivalence of barleys differing only in low- and normal-phytate levels,” J Agric Food Chem., 60(26), 6493-8, 2012.
[6] M. S.Islam, R. Nagasaka, K. Ohara, T. Hosoya, H. Ozaki, H. Ushio, and M. Hori, “Biological abilities of rice bran-derived antioxidant phytochemicals for medical therapy,” Curr Top Med Chem., 11(14), 1847-53, 2011.
[7] S. Y. Al-Okbi, N. M. Ammar, D. A. Mohamed, I. M. Hamed, A. H. Desoky, H. F. El-Bakry, and A. M. Helal, “Egyptian rice bran oil: chemical analysis of the main phytochemicals (Periodical style— Accepted for publication),” La Rivista Italiana delle Sostanze Grasse, to be published.
[8] S. Y. Al-Okbi, Prevention and Management of Some Chronic Diseases (Renal and hepatic) by Nutraceuticals and Functional Foods (2010- 2013), a project in National Research Centre, Egypt.
[9] N. Erdinest, O.Shmueli, Y. Grossman, H. Ovadia, and A. Solomon, “Anti-inflammatory effects of alpha linolenic acid on human corneal epithelial cells,”. Invest Ophthalmol Vis Sci., 53(8), 4396-406. 2012.
[10] T. E. Sialvera, G. D. Pounis, A. E. Koutelidakis, D. J. Richter, G. Yfanti, M. Kapsokefalou, G. Goumas, N. Chiotinis, E. Diamantopoulos, and A. Zampelas, “Phytosterols supplementation decreases plasma small and dense LDL levels in metabolic syndrome patients on a westernized type diet.” Nutr Metab Cardiovasc Dis., 22(10), 843-8, 2012.
[11] M. Lutz, K. Jorquera , B. Cancino B, R. Ruby, and C. Henriquez, “Phenolics and antioxidant capacity of table grape (Vitis vinifera L.) Cultivars grown in Chile.” J Food Sci., 76(7), C1088-93, 2011.
[12] A.O.A.C., "Official Methods of Analysis of the Association of Official Analytical Chemists," 17th ed., Association of Official Analytical Chemists, Arlington, Virginia, USA, 2000.
[13] K. Satoh, “Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method,” Clinica Chimica Acta, 20, 37-43, 1978.
[14] T. Koeda, K. Wakaki, F. Koizumi, T. Yokozawa, and H. Oura, “Early changes of proximal tubules in the kidney of adenine-ingesting rats, with special reference to biochemical and electron microscopic studies,” Nippon Jinzo Gakkai Shi, 30: 239–46, 1998.
[15] J. A. Stepaniak, K. E. Gould, D. Sun, and R. H. Swanborg, ”A comparative study of experimental autoimmune encephalomyelitis in Lewis and DA rats, “ J Immunol., 155, 2762-2769, 1995.
[16] Houot O. 1985. “Interpretation of clinical laboratory tests,” G. Siest, J. Henny, F. Schiele, D. S. Young, edits., Biomedical publications, 1985.
[17] J. K. Fawcett, J. E. Scott, “A rapid and precise method for the determination of urea,” J. Clin. Pathol., 13, 156-159, 1960.
[18] B. T. Doumas, W. A.Watson, and H. G. Biggs, “Albumin standards and the measurement of serum albumin with bromocresol green,” Clin. Chem. Acta., 1972, 31, 87, 1972.
[19] D. A. Watson, “Simple method for the determination of serum cholesterol,” Clin. Chem. Acta., 5, 637-642, 1960.
[20] H. Schriewer, U. Kohnert, G. Assmann, “Determination of LDL cholesterol and LDL apolipoprotein B following precipitation of VLDL in blood serum with phosphotungstic acid/MgCl2,” J. Clin. Chem. Clin. Biochem., 22, 35-40, 1984.
[21] K. Katsumata, K. Kenichiro, H. Michinori, T. Kunihiko, N. Nobuo, K. B. Steven, “Sevelamer hydrochloride prevents ectopic calcification and renal osteodystro- phy in chronic renal failure rats,” Kidney Int., 64, 441–50, 2003.
[22] M. Shuvy, S. Abedat , R. Beeri, H. D. Danenberg, D. Planer, I. Z. Ben- Dov, K. Meir, J. Sosna, and C. Lotan, “Uraemic hyperparathyroidism causes a reversible inflammatory process of aortic valve calcification in rats,” Cardiovascular Research, 79, 492–499, 2008.
[23] H. Okada, Y. Kaneko, T. Yawata, et al: “Reversibility of adenineinduced renal failure in rats,” Clin Exp Nephrol., 3, 82–88, 1999.
[24] M. Tonelli, N. Pannu and B. Manns, “Oral Phosphate Binders in Patients with Kidney Failure, ” N Engl J Med., 362, 1312-1324, 2010.
[25] D. Foque, K. Kalantar-Zadeh, J. D. Kopple, N. Canau, P. Chauveau, L. Cuppari, H. Franch, G. Guarnieri, T. A. Ikizler, and G. A. Kaysen, “Proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease,” Kidney Int., 73, 391-398, 2008.
[26] A. Bonanni, I. Mannucci, D. Verzola, A. Sofia, S. Saffioti, E. Gianetta, and G. Garibotto, “Protein-Energy Wasting and Mortality in Chronic Kidney Disease,” Int. J. Environ. Res. Public Health, 8, 1631-1654, 2011.
[27] K. Kalantar-Zadeh, R. D. Kilpatrick, and N. Kuwae, “Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction,” Nephrol. Dial. Transpl., 20, 1880-1888, 2005.
[28] T. A. Ikizler, R. I. Wingard, J. Harvell, Y. Shyr, and R. Hakim, “Association of morbidity with markers of nutrition and inflammation in chronic hemodialysis patients: A prospective study,” Kidney Int., 55, 1945-1951, 1999.
[29] G. M. Chertow, D. J. Goldstein-Fuchs, J. M. Lazarus, G. A. Kaysen, “Prealbumin, mortality, and cause-specific hospitalization in hemodialysis patients. Kidney Int., 68, 2794-2800, 2005.
[30] P. Stenvinkel, O. Haimburger, F. Paultre, U. Diczfalusy, T. Wang, L. Berglund, and T. Jogestrand, “Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure,” Kidney Int., 55, 1899-1911, 1999.
[31] V. Panichi, M. Migliori, S. De Pietro, D. Taccola, A. M. Bianchi, L. Giovannini, M. Norpoth, M. R. Metelli, R. Cristofani, A. A. Bertelli, “Creactive protein and interleukin-6 levels are related to renal function in predialytic chronic renal failure,” Nephron, 91, 594-600, 2002.
[32] T. Nguyen-Khoa, Z. A. Massay, J. P. De Bandt, M. Kebede, L. Salama, G. Lambrey, V. Witko-Sarsat, T. B. Drüeke, B. Lacour, and M. Thévenin, “Oxidative stress and haemodialysis: Role of inflammation and duration of dialysis treatment,” Nephrol. Dial. Transpl., 16, 335- 340, 2001.
[33] G. Ding, H. Van Goor, S. D. Ricardo, J. M. Orlowski, and J. R. Diamond, “Oxidized LDL stimulates the expression of TGF and fibronectin in human glomerular epithelial cells,” Kidney Int., 51, 147– 154, 1997.
[34] E. F. Gris, F. Mattivi, E. A. Ferreira, U. Vrhovsek, D. W. Filho, R. C. Pedrosa, M. T. Bordignon-Luiz, “Stilbenes and tyrosol as target compounds in the assessment of antioxidant and hypolipidemic activity of Vitis vinifera red wines from southern Brazil.” J Agric Food Chem., 59(14), 7954-61, 2011.
[35] G. M. Cole, G. P. Lim, and F. Yang, “Prevention of Alzheimer's disease: Omega-3 fatty acid and phenolic antioxidant interventions,” Neurobiol. Aging, 26S, S133 - S136, 2005.
[36] Rho K.A., Kim M.K. Effects of different grape formulations on antioxidative capacity, lipid peroxidation and oxidative DNA damage in aged rats. J. Nutr. Sci. Vitaminol., Tokyo 2006; 52 (1): 33 - 46.
[37] J. A. Pereira, I. Oliveira, A. Sousa, I. Ferreira, A. Bento, and L. Estevinho, “Bioactive properties and chemical composition of six walnut (Juglans regia L.) cultivars,” Food Chem. Toxicol., 46, 2103–2111, 2008.
[38] T. Fukuda, H. Ito, and T. Yoshida, “Antioxidative polyphenols from walnuts (Juglans regia L.),” Phytochemistry, 63, 795–801, 2003.
[39] M. Colaric, R. Veberic, A. Solar, M. Hudina, and F. Stampar, “Phenolic acids, syringaldehyde, and juglone in fruits of different cultivars of Juglans regia L,” J. Agr. Food Chem., 53, 6390–6396, 2005.
[40] B. Muthaiyah, M. M. Essa, V. Chauhan, A. Chauhan, “Protective effects of walnut extract against amyloid beta peptide-induced cell death and oxidative stress in PC12 cells,” Neurochem Res., 36(11), 2096-103, 2011.
[41] S. Khatoon, and A. G. Gopalakrishna, “Fat-soluble nutraceuticals and fatty acid composition of selected Indian rice varieties,” Journal of the American Oil Chemists’ Society, 81, 939–943, 2004.
[42] H. Ardiansyah Shirakawa, T. Koseki, K. Ohinata, K. Hazhizume, and M. Komai, “Rice bran fractions improve blood pressure, lipid profile, and glucose metabolism in stroke-prone spontaneously hypertensive rats,” Journal of Agricultural and Food Chemistry, 54, 1914–1920, 2006.
[43] Y. Saito, K. Ikushima, S. Hatakeda, T. Ito, and T. Goto, “Fractional extraction of rice bran oil and its esters with supercritical carbon dioxide,” Int. Chem.Eng., 33, 307 – 314, 1993.
[44] S. Christie, A. F. Walker, and G. T. Lewith, “Flavonoids - a new direction for the treatment of fluid retention, “ Phytother Res ,15:, 467– 475, 2001.
[45] K. K. Hullatti, U. V. Gopikrishna, I.J.J Kuppast, “Phytochemical investigation and diuretic activity of Cyclea peltata leaf extracts”, . Adv Pharm Technol Res., 2(4), 241-4, 2011.
[46] F. Van Lente, and P. Sult, “Assessment of renal function by serum creatinine and creatinine clearance: Glomerular filteration rate estimated by four procedures,” Clin.Chem., 35 (12): 2326-2330, 1989.